Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;22(1):16-9.

Home IV Antibiotic Therapy and Exercise Capacity in Children with CF: A Case Series

Affiliations

Home IV Antibiotic Therapy and Exercise Capacity in Children with CF: A Case Series

Narelle S Cox et al. Cardiopulm Phys Ther J. 2011 Mar.

Abstract

Purpose: This case series describes the effect of home intravenous (IV) antibiotic therapy on spirometry and exercise capacity in a group of children with cystic fibrosis (CF).

Methods: Outcomes from 10 children with CF who were prescribed a 14-day course of home IV antibiotics for a respiratory exacerbation are reported. All children performed spirometry and a modified shuttle test (MST) before and after 14-days of home IV therapy.

Results: After 14 days, FEV(1) increased by mean (± SE) 12 ± 4 % (p < 0.05) but mean MST did not improve compared to baseline. All children improved or maintained spirometry values with treatment, however, only 5 improved MST distance.

Conclusion: After 14 days of home IV antibiotic therapy, a significant improvement in spirometry, but not exercise capacity, was seen in this small series of children with CF. The lack of improvement in exercise capacity for all children following home IV antibiotic therapy suggests factors other than spirometry determine exercise capacity. Identifying and investigating the factors that influence exercise capacity during home IV antibiotic therapy requires further investigation.

Keywords: FEV1; Modified Shuttle Test; cystic fibrosis; home IV therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Rating of Perceived Exertion Scale.

Similar articles

Cited by

References

    1. Rubin BK. Emerging therapies for cystic fibrosis lung disease. Chest. 1999;115:1120–1126. - PubMed
    1. Smith AL. Antibiotic therapy in cystic fibrosis: Evaluation of clinical trials. J Pediatr. 1986;108(2):866–870. - PubMed
    1. Asensio O, Bosque M, Marco T, de Gracia J, Serra C. Home intravenous antibiotics for cystic fibrosis (Review). Cochrane DB Syst Rev. 2000, Issue 4. Art. No.: CD001917. - PubMed
    1. Orenstein DM, Nixon PA, Ross EA, Kaplan RM. The quality of well-being in cystic fibrosis. Chest. 1989;95:344–347. - PubMed
    1. Nixon PA, Orentsein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med. 1992;327:1785–1788. - PubMed